ArticleFrontiers in neuroscience2025
LLM-based feature selection and counterfactual explanations applied to functional connectivity analysis in schizophrenia.
Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Schizophrenia (SZ) is a complex psychiatric disorder whose neural mechanisms are still unclear. Functional connectivity (FC) provides a unique perspective for understanding its pathology, but its high-dimensional nature poses significant challenges for feature selection and model interpretation. Traditional feature selection methods, while predictive, lack the integration of prior neuroscience knowledge, resulting in limited clinical relevance. Methods: To address this, we propose an innovative framework that combines feature selection guided by a large language model (LLM) with counterfactual explanation. This framework leverages brain disease knowledge encoded by the LLM to guide dimensionality reduction of high-dimensional FC, ensuring that selected features are both statistically significant and biologically plausible. Counterfactual explanations are then used to generate causal intervention examples, which are then translated by the LLM into intuitive explanations in natural language, providing understandable and actionable clinical insights for individual patients or physicians. Results: We validate our approach on five real-world SZ datasets and demonstrate that it not only improves model classification performance but also provides new insights into SZ analysis. Discussion: The LLM-based FC analysis method proposed in this study demonstrates good feature selection and interpretability on multiple SZ datasets. Its main advantage is its ability to effectively screen key FC features for brain regions. However, this method has some limitations, such as being difficult to directly apply clinically due to data heterogeneity, being unable to accurately locate individual FC abnormalities, and the hyperparameters for counterfactual generation not yet being optimized.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.